Generic Bosulif (bosutinib) – FDA cGMP Manufacturer

Key Features:

- Dosage: Typically 400-600mg orally once daily, with or without food.

- Mechanism of Action: Bosutinib is a tyrosine kinase inhibitor (TKI) that blocks the activity of certain proteins that promote cancer cell growth.

- Side Effects: Common side effects include diarrhea, nausea, vomiting, abdominal pain, and fatigue.

Manufacturer Information:

- FDA cGMP Certified: Ensure the manufacturer is certified by the FDA to guarantee quality and safety.

- Various Manufacturers: Multiple pharmaceutical companies produce generic bosutinib, including those in India and other countries.

Important Considerations:

- Prescription Required: A doctor's prescription is necessary to purchase Generic Bosulif.

- Monitoring: Regular blood tests and liver function tests are required to monitor for potential side effects.

- Interactions: May interact with certain medications, such as CYP3A4 inhibitors or inducers.